Want to see ONC full AI Analyst Report?
ETFs with BeOne Medicines (ONC) Exposure
The following ETFs maintain exposure to BeOne Medicines (ONC). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
50 ETFs Hold BeOne Medicines (ONC)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in ONC |
|---|---|---|---|---|---|---|
| CANC | Tema Oncology ETF | $216.18M | 0.75% | 3.75% | $8.10M | 0.02% |
| 1FU6 | First Trust NYSE Arca Biotechnology UCITS ETF | $18.87M | 0.63% | 3.32% | $623.64K | <0.01% |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | $3.14B | 0.55% | 3.32% | $103.68M | 0.26% |
| MCHS | Matthews China Discovery Active ETF | $13.72M | 0.89% | 2.76% | $364.78K | <0.01% |
| BBH | VanEck Biotech ETF | $522.74M | 0.35% | 2.67% | $13.94M | 0.03% |
| MINV | Matthews Asia Innovators Active ETF | $152.77M | 0.79% | 2.59% | $3.87M | 0.00% |
| AGNG | Global X Aging Population ETF | $95.50M | 0.50% | 2.59% | $2.46M | <0.01% |
| BIOT | L&G Pharma Breakthrough UCITS ETF | $32.96M | 0.49% | 2.51% | $853.61K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 2.12% | $243.30M | 0.60% |
| BBP | Virtus LifeSci Biotech Products ETF | $136.83M | 0.34% | 1.81% | $2.45M | <0.01% |
| NSI | National Security Emerging Markets Index ETF | $40.92M | 0.75% | 1.70% | $678.81K | <0.01% |
| XGEN | Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF Accum-1C- USD | $14.78M | 0.36% | 1.57% | $240.03K | <0.01% |
| SELJLB | Selectra Investments SICAV - J. Lamarck Biotech | $408.04K | 3.36% | 1.35% | $902.04K | <0.01% |
| EDGE.U | Evolve Innovation Index Fund Trust Units -Unhedged- | $695.92K | 0.70% | 1.27% | $486.08K | <0.01% |
| EDGE | Evolve Innovation Index Fund | $32.83M | 0.71% | 1.27% | $486.08K | <0.01% |
| ADRE | ― | ― | ― | 1.13% | $1.42M | <0.01% |
| ESIM | Eventide International ETF | $29.98M | 0.59% | 0.99% | $293.67K | <0.01% |
| EMEQ | Macquarie Focused Emerging Markets Equity ETF | $612.06M | 0.85% | 0.93% | $5.72M | 0.01% |
| FNI | ― | ― | ― | 0.91% | $680.19K | <0.01% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.85% | $11.31M | 0.03% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.84% | $1.02M | <0.01% |
| CAPI | Capital Group International Equity Select ETF | $228.75M | 0.92% | 0.77% | $1.52M | <0.01% |
| MTRA | Invesco International Growth Focus ETF | $129.69M | 0.54% | 0.75% | $948.79K | <0.01% |
| CGGO | Capital Group Global Growth Equity ETF | $11.90B | 0.47% | 0.74% | $88.24M | 0.22% |
| NDOW | Anydrus Advantage ETF | $72.91M | 2.11% | 0.73% | $494.39K | <0.01% |
| CGGE | Capital Group Global Equity ETF | $3.30B | 0.47% | 0.72% | $23.52M | 0.06% |
| CGIE | Capital Group International Equity ETF | $2.46B | 0.54% | 0.62% | $15.32M | 0.04% |
| THNZ | ― | ― | ― | 0.54% | $20.59K | <0.01% |
| ZGEN | ― | ― | ― | 0.51% | $15.02K | <0.01% |
| CGNG | Capital Group New Geography Equity ETF | $3.06B | 0.64% | 0.46% | $13.97M | 0.03% |
| WBEM | William Blair Emerging Markets Equity ETF | ― | 0.65% | 0.37% | $35.84K | <0.01% |
| FFEM | Fidelity Fundamental Emerging Markets ETF | $62.11M | 0.60% | 0.32% | $197.67K | <0.01% |
| SPWO | SP Funds S&P World (ex-US) ETF | $244.75M | 0.55% | 0.30% | $736.43K | <0.01% |
| HELX | Franklin Genomic Advancements ETF | $36.80M | 0.50% | 0.26% | $95.17K | <0.01% |
| APIE | ActivePassive International Equity ETF | $1.13B | 0.45% | 0.21% | $2.33M | <0.01% |
| DFSE | Dimensional Emerging Markets Sustainability Core 1 ETF | $600.94M | 0.41% | 0.10% | $583.35K | <0.01% |
| FTLS | First Trust Long/Short Equity ETF | $2.66B | 1.38% | 0.09% | $2.40M | <0.01% |
| 0B4A | ― | ― | ― | 0.09% | $1.00M | <0.01% |
| JSTC | Adasina Social Justice All Cap Global ETF | $300.92M | 0.89% | 0.07% | $206.59K | <0.01% |
| DFEM | Dimensional Emerging Markets Core Equity 2 ETF | $9.08B | 0.39% | 0.07% | $6.09M | 0.01% |
| DFAE | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | 0.06% | $5.84M | 0.01% |
| EMEE | iShares Emerging Markets Equity Enhanced Active UCITS ETF | $1.57B | 0.79% | 0.06% | $977.95K | <0.01% |
| EMME | Ishares Iii PLC - iShares Emerging Markets Equity Enhanced Active UCITS ETF USD | $177.59M | 0.81% | 0.06% | $977.95K | <0.01% |
| AVSE | Avantis Responsible Emerging Markets Equity ETF | $222.20M | 0.33% | 0.03% | $73.20K | <0.01% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | 0.03% | $3.39M | <0.01% |
| DEHP | Dimensional Emerging Markets High Profitability ETF | $422.67M | 0.41% | 0.03% | $121.87K | <0.01% |
| AVEM | Avantis Emerging Markets Equity ETF | $27.48B | 0.33% | 0.02% | $4.19M | 0.01% |
| DFAX | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | <0.01% | $811.12K | <0.01% |
| FEMR | Fidelity Enhanced Emerging Markets ETF | $205.17M | 0.38% | <0.01% | $11.52K | <0.01% |
| AVNC | Avantis All International Core Equity ETF | $99.60M | 0.27% | <0.01% | $743.12 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in ONC |
|---|---|---|---|---|---|---|
| CANC | 3.75% | Tema Oncology ETF | $216.18M | 0.75% | $8.10M | 0.02% |
| 1FU6 | 3.32% | First Trust NYSE Arca Biotechnology UCITS ETF | $18.87M | 0.63% | $623.64K | <0.01% |
| FBT | 3.32% | First Trust NYSE Arca Biotechnology Index Fund | $3.14B | 0.55% | $103.68M | 0.26% |
| MCHS | 2.76% | Matthews China Discovery Active ETF | $13.72M | 0.89% | $364.78K | <0.01% |
| BBH | 2.67% | VanEck Biotech ETF | $522.74M | 0.35% | $13.94M | 0.03% |
| MINV | 2.59% | Matthews Asia Innovators Active ETF | $152.77M | 0.79% | $3.87M | 0.00% |
| AGNG | 2.59% | Global X Aging Population ETF | $95.50M | 0.50% | $2.46M | <0.01% |
| BIOT | 2.51% | L&G Pharma Breakthrough UCITS ETF | $32.96M | 0.49% | $853.61K | <0.01% |
| IBB | 2.12% | iShares Biotechnology ETF | $11.52B | 0.44% | $243.30M | 0.60% |
| BBP | 1.81% | Virtus LifeSci Biotech Products ETF | $136.83M | 0.34% | $2.45M | <0.01% |
| NSI | 1.70% | National Security Emerging Markets Index ETF | $40.92M | 0.75% | $678.81K | <0.01% |
| XGEN | 1.57% | Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF Accum-1C- USD | $14.78M | 0.36% | $240.03K | <0.01% |
| SELJLB | 1.35% | Selectra Investments SICAV - J. Lamarck Biotech | $408.04K | 3.36% | $902.04K | <0.01% |
| EDGE.U | 1.27% | Evolve Innovation Index Fund Trust Units -Unhedged- | $695.92K | 0.70% | $486.08K | <0.01% |
| EDGE | 1.27% | Evolve Innovation Index Fund | $32.83M | 0.71% | $486.08K | <0.01% |
| ADRE | 1.13% | ― | ― | ― | $1.42M | <0.01% |
| ESIM | 0.99% | Eventide International ETF | $29.98M | 0.59% | $293.67K | <0.01% |
| EMEQ | 0.93% | Macquarie Focused Emerging Markets Equity ETF | $612.06M | 0.85% | $5.72M | 0.01% |
| FNI | 0.91% | ― | ― | ― | $680.19K | <0.01% |
| OM3E | 0.85% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $11.31M | 0.03% |
| IBBQ | 0.84% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $1.02M | <0.01% |
| CAPI | 0.77% | Capital Group International Equity Select ETF | $228.75M | 0.92% | $1.52M | <0.01% |
| MTRA | 0.75% | Invesco International Growth Focus ETF | $129.69M | 0.54% | $948.79K | <0.01% |
| CGGO | 0.74% | Capital Group Global Growth Equity ETF | $11.90B | 0.47% | $88.24M | 0.22% |
| NDOW | 0.73% | Anydrus Advantage ETF | $72.91M | 2.11% | $494.39K | <0.01% |
| CGGE | 0.72% | Capital Group Global Equity ETF | $3.30B | 0.47% | $23.52M | 0.06% |
| CGIE | 0.62% | Capital Group International Equity ETF | $2.46B | 0.54% | $15.32M | 0.04% |
| THNZ | 0.54% | ― | ― | ― | $20.59K | <0.01% |
| ZGEN | 0.51% | ― | ― | ― | $15.02K | <0.01% |
| CGNG | 0.46% | Capital Group New Geography Equity ETF | $3.06B | 0.64% | $13.97M | 0.03% |
| WBEM | 0.37% | William Blair Emerging Markets Equity ETF | ― | 0.65% | $35.84K | <0.01% |
| FFEM | 0.32% | Fidelity Fundamental Emerging Markets ETF | $62.11M | 0.60% | $197.67K | <0.01% |
| SPWO | 0.30% | SP Funds S&P World (ex-US) ETF | $244.75M | 0.55% | $736.43K | <0.01% |
| HELX | 0.26% | Franklin Genomic Advancements ETF | $36.80M | 0.50% | $95.17K | <0.01% |
| APIE | 0.21% | ActivePassive International Equity ETF | $1.13B | 0.45% | $2.33M | <0.01% |
| DFSE | 0.10% | Dimensional Emerging Markets Sustainability Core 1 ETF | $600.94M | 0.41% | $583.35K | <0.01% |
| FTLS | 0.09% | First Trust Long/Short Equity ETF | $2.66B | 1.38% | $2.40M | <0.01% |
| 0B4A | 0.09% | ― | ― | ― | $1.00M | <0.01% |
| JSTC | 0.07% | Adasina Social Justice All Cap Global ETF | $300.92M | 0.89% | $206.59K | <0.01% |
| DFEM | 0.07% | Dimensional Emerging Markets Core Equity 2 ETF | $9.08B | 0.39% | $6.09M | 0.01% |
| DFAE | 0.06% | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | $5.84M | 0.01% |
| EMEE | 0.06% | iShares Emerging Markets Equity Enhanced Active UCITS ETF | $1.57B | 0.79% | $977.95K | <0.01% |
| EMME | 0.06% | Ishares Iii PLC - iShares Emerging Markets Equity Enhanced Active UCITS ETF USD | $177.59M | 0.81% | $977.95K | <0.01% |
| AVSE | 0.03% | Avantis Responsible Emerging Markets Equity ETF | $222.20M | 0.33% | $73.20K | <0.01% |
| ONEQ | 0.03% | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | $3.39M | <0.01% |
| DEHP | 0.03% | Dimensional Emerging Markets High Profitability ETF | $422.67M | 0.41% | $121.87K | <0.01% |
| AVEM | 0.02% | Avantis Emerging Markets Equity ETF | $27.48B | 0.33% | $4.19M | 0.01% |
| DFAX | <0.01% | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | $811.12K | <0.01% |
| FEMR | <0.01% | Fidelity Enhanced Emerging Markets ETF | $205.17M | 0.38% | $11.52K | <0.01% |
| AVNC | <0.01% | Avantis All International Core Equity ETF | $99.60M | 0.27% | $743.12 | <0.01% |
Popular ETF Comparisons
ONC ETF Exposure FAQ
What ETFs hold BeOne Medicines stock?
BeOne Medicines (ONC) is currently held by 50 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to ONC include iShares (IBB), First Trust (FBT) and VanEck (BBH).
Which ETF has the largest exposure to ONC?
The ETF with the largest exposure to ONC is iShares (IBB), with approximately $243.30M in market value exposure.
How much ONC stock is held by ETFs?
ETFs currently hold approximately $379.66M worth of BeOne Medicines (ONC) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.